These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 33204322)

  • 1. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.
    Sun L; Huang C; Zhu M; Guo S; Gao Q; Wang Q; Chen B; Li R; Zhao Y; Wang M; Chen Z; Shen B; Zhu W
    Theranostics; 2020; 10(26):11950-11962. PubMed ID: 33204322
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells.
    Wang Q; Huang C; Ding Y; Wen S; Wang X; Guo S; Gao Q; Chen Z; Zhao Y; Wang M; Shen B; Zhu W
    Front Immunol; 2022; 13():884373. PubMed ID: 35572560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conditional medium of gastric cancer mesenchymal stem cells promotes PD-L1 expression in gastric cancer cells and tumor growth via upregulating VGLL4].
    Ding Y; Zhu W; Wang Q; Chen B; Wang M; Zhao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):321-327. PubMed ID: 35583061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis.
    Sun L; Wang Q; Chen B; Zhao Y; Shen B; Wang H; Xu J; Zhu M; Zhao X; Xu C; Chen Z; Wang M; Xu W; Zhu W
    Cell Death Dis; 2018 Sep; 9(9):928. PubMed ID: 30206229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced gastric cancer growth potential of mesenchymal stem cells derived from gastric cancer tissues educated by CD4
    Xu R; Zhao X; Zhao Y; Chen B; Sun L; Xu C; Shen B; Wang M; Xu W; Zhu W
    Cell Prolif; 2018 Apr; 51(2):e12399. PubMed ID: 29057538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer mesenchymal stem cells via the CXCR2/HK2/PD-L1 pathway mediate immunosuppression.
    Huang C; Chen B; Wang X; Xu J; Sun L; Wang D; Zhao Y; Zhou C; Gao Q; Wang Q; Chen Z; Wang M; Zhang X; Xu W; Shen B; Zhu W
    Gastric Cancer; 2023 Sep; 26(5):691-707. PubMed ID: 37300724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer.
    Wang Q; Huang C; Wang D; Tao Z; Zhang H; Zhao Y; Wang M; Zhou C; Xu J; Shen B; Zhu W
    Cell Signal; 2023 Jun; 106():110639. PubMed ID: 36842523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells.
    Gao Q; Huang C; Liu T; Yang F; Chen Z; Sun L; Zhao Y; Wang M; Luo L; Zhou C; Zhu W
    J Cell Biochem; 2024 Mar; 125(3):e30521. PubMed ID: 38226525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Gastric Cancer Mesenchymal Stem Cell-Derived IL15 Contributes to Tumor Cell Epithelial-Mesenchymal Transition via Upregulation Tregs Ratio and PD-1 Expression in CD4
    Sun L; Wang Q; Chen B; Zhao Y; Shen B; Wang X; Zhu M; Li Z; Zhao X; Xu C; Chen Z; Wang M; Xu W; Zhu W
    Stem Cells Dev; 2018 Sep; 27(17):1203-1214. PubMed ID: 29901436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-873/PD-L1 axis regulates the stemness of breast cancer cells.
    Gao L; Guo Q; Li X; Yang X; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Xi T; Zheng L
    EBioMedicine; 2019 Mar; 41():395-407. PubMed ID: 30803931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.
    Wei F; Zhang T; Deng SC; Wei JC; Yang P; Wang Q; Chen ZP; Li WL; Chen HC; Hu H; Cao J
    Cancer Lett; 2019 May; 450():1-13. PubMed ID: 30776481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
    Komura N; Mabuchi S; Shimura K; Yokoi E; Kozasa K; Kuroda H; Takahashi R; Sasano T; Kawano M; Matsumoto Y; Kodama M; Hashimoto K; Sawada K; Kimura T
    Cancer Immunol Immunother; 2020 Dec; 69(12):2477-2499. PubMed ID: 32561967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
    Zhang Y; Wang F; Sun HR; Huang YK; Gao JP; Huang H
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2209-2222. PubMed ID: 33891173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
    Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
    Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice.
    Kim W; Chu TH; Nienhüser H; Jiang Z; Del Portillo A; Remotti HE; White RA; Hayakawa Y; Tomita H; Fox JG; Drake CG; Wang TC
    Gastroenterology; 2021 Feb; 160(3):781-796. PubMed ID: 33129844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy.
    Morrissey SM; Yan J
    Trends Cancer; 2020 Jul; 6(7):550-558. PubMed ID: 32610067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
    Yang MW; Fu XL; Jiang YS; Chen XJ; Tao LY; Yang JY; Huo YM; Liu W; Zhang JF; Liu PF; Liu Q; Hua R; Zhang ZG; Sun YW; Liu DJ
    World J Gastroenterol; 2019 Apr; 25(14):1684-1696. PubMed ID: 31011254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer.
    Liao TT; Lin CC; Jiang JK; Yang SH; Teng HW; Yang MH
    Theranostics; 2020; 10(14):6095-6112. PubMed ID: 32483441
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research advances in the role of gastric cancer‑derived mesenchymal stem cells in tumor progression (Review).
    Shen J; Zhu W
    Int J Mol Med; 2021 Feb; 47(2):455-462. PubMed ID: 33416102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.